144 related articles for article (PubMed ID: 3594434)
1. Development of an experimental model for studying bladder carcinogen metabolism using the isolated rat urinary bladder.
Airoldi L; Bonfanti M; Magagnotti C; Fanelli R
Cancer Res; 1987 Jul; 47(14):3697-700. PubMed ID: 3594434
[TBL] [Abstract][Full Text] [Related]
2. Experimental model for investigating bladder carcinogen metabolism using the isolated rat urinary bladder.
Airoldi L; Bonfanti M; Magagnotti C; Fanelli R
IARC Sci Publ; 1987; (84):159-61. PubMed ID: 3679358
[TBL] [Abstract][Full Text] [Related]
3. In vitro metabolism of bladder carcinogenic nitrosamines by rat liver and urothelial cells.
Airoldi L; Magagnotti C; De Gregorio G; Moret M; Fanelli R
Chem Biol Interact; 1992 Apr; 82(2):231-40. PubMed ID: 1568272
[TBL] [Abstract][Full Text] [Related]
4. Alpha-oxidative metabolism of the bladder carcinogens N-nitrosobutyl(4-hydroxybutyl)amine and N-nitrosobutyl(3-carboxypropyl)amine within the rat isolated bladder.
Airoldi L; Magagnotti C; Bonfanti M; Fanelli R
Carcinogenesis; 1990 Aug; 11(8):1437-40. PubMed ID: 2387032
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetic profile and metabolism of N-nitrosobutyl-(4-hydroxybutyl)amine in rats.
Bonfanti M; Magagnotti C; Bonati M; Fanelli R; Airoldi L
Cancer Res; 1988 Jul; 48(13):3666-9. PubMed ID: 3378210
[TBL] [Abstract][Full Text] [Related]
6. N-Nitrosobutyl(4-hydroxybutyl)amine alpha-hydroxylation by rat liver and urothelial cell homogenates.
Airoldi L; Magagnotti C; Bonfanti M; Moret M; Fanelli R
IARC Sci Publ; 1991; (105):343-5. PubMed ID: 1855877
[TBL] [Abstract][Full Text] [Related]
7. Effect of butylated hydroxyanisole on the metabolism of N-nitrosodi-n-butylamine and N-nitrosobutyl(4-hydroxybutyl)amine by rat hepatic S9 preparations in vitro.
Pastorelli R; Ancidei A; Fanelli R; Airoldi L
IARC Sci Publ; 1987; (84):183-4. PubMed ID: 3679366
[TBL] [Abstract][Full Text] [Related]
8. Mechanism of action of the urinary bladder carcinogen N-nitrosobutyl-3-carboxypropylamine.
Janzowski C; Jacob D; Henn I; Zankl H; Pool-Zobel BL; Wiessler M; Eisenbrand G
IARC Sci Publ; 1991; (105):332-8. PubMed ID: 1855875
[TBL] [Abstract][Full Text] [Related]
9. Escherichia coli infection of the urinary bladder: induction of tumours in rats receiving nitrosamine precursors and augmentation of bladder carcinogenesis by N-nitrosobutyl (4-hydroxybutyl)amine.
Higgy NA; Verma AK; Ertürk E; Oberley TD; el-Aaser AA; el-Merzabani MM; Bryan GT
IARC Sci Publ; 1987; (84):380-3. PubMed ID: 3315999
[TBL] [Abstract][Full Text] [Related]
10. Species variations in the metabolism of N-butyl-N-(4-hydroxybutyl) nitrosamine and related compounds in relation to urinary bladder carcinogenesis.
Suzuki E; Anjo T; Aoki J; Okada M
Gan; 1983 Feb; 74(1):60-8. PubMed ID: 6840438
[TBL] [Abstract][Full Text] [Related]
11. Metabolic fate of N-butyl-N-(4-hydroxybutyl)nitrosamine homologs in the rat, in relation to their organotropic carcinogenicity to the urinary bladder.
Suzuki E; Iiyoshi M; Okada M
Gan; 1981 Feb; 72(1):113-22. PubMed ID: 7274637
[TBL] [Abstract][Full Text] [Related]
12. Metabolic fate and carcinogenicity of N-(omega-hydroxyalkyl) N-(4-hydroxybutyl) nitrosamines analogs of N-butyl-N-(4-hydroxy-butyl) nitrosamine, in the rat.
Suzuki E; Takeda Y; Mochizuki M; Hashimoto Y; Okada M
Gan; 1981 Aug; 72(4):539-46. PubMed ID: 7308665
[TBL] [Abstract][Full Text] [Related]
13. Detection of O6-butyl- and O6-(4-hydroxybutyl)guanine in urothelial and hepatic DNA of rats given the bladder carcinogen N-nitrosobutyl(4-hydroxybutyl)amine.
Airoldi L; Magagnotti C; Bonfanti M; Chiappetta L; Lolli M; Medana C; De Gregorio G; Fanelli R
Carcinogenesis; 1994 Oct; 15(10):2297-301. PubMed ID: 7955070
[TBL] [Abstract][Full Text] [Related]
14. Intestinal first-pass metabolism of nitrosamines. 2. Metabolism of N-nitrosodibutylamine in isolated perfused rat small intestinal segments.
Richter E; Zwickenpflug W; Wiessler M
Carcinogenesis; 1988 Mar; 9(3):499-506. PubMed ID: 3345589
[TBL] [Abstract][Full Text] [Related]
15. Metabolic fate of N-butyl-N-(4-hydroxybutyl)nitrosamine in the rat.
Suzuki E; Okada M
Gan; 1980 Dec; 71(6):856-62. PubMed ID: 7274630
[TBL] [Abstract][Full Text] [Related]
16. Metabolic fate of N-alkyl-N-(3-hydroxypropyl and 2-hydroxy-ethyl)nitrosamines in the rat in relation to the induction of bladder cancer by N-butyl-N-(4-hydroxybutyl)nitrosamine and its homologs.
Suzuki E; Iiyoshi M; Okada M
Gan; 1981 Apr; 72(2):254-8. PubMed ID: 7286549
[TBL] [Abstract][Full Text] [Related]
17. Nrf2 and p53 cooperatively protect against BBN-induced urinary bladder carcinogenesis.
Iida K; Itoh K; Maher JM; Kumagai Y; Oyasu R; Mori Y; Shimazui T; Akaza H; Yamamoto M
Carcinogenesis; 2007 Nov; 28(11):2398-403. PubMed ID: 17602169
[TBL] [Abstract][Full Text] [Related]
18. [An experimental study on bladder carcinogenesis in dogs by N-butyl-N-(4-hydroxybutyl) nitrosamine (BBN) and its urinary metabolites].
Morishita S; Hamami G; Kamidono S
Hinyokika Kiyo; 1989 Jan; 35(1):27-38. PubMed ID: 2729018
[TBL] [Abstract][Full Text] [Related]
19. Investigations on organ-specific metabolism and genotoxic effects of the urinary bladder carcinogen N-nitrosobutyl-3-carboxypropylamine (BCPN) and its analogs N-nitrosodibutylamine (NDBA) and N-nitrosobutyl-4-hydroxybutylamine (4-OH-NDBA).
Janzowski C; Jacob D; Henn I; Zankl H; Poole-Zobel BL; Eisenbrand G
Toxicology; 1989 Dec; 59(2):195-209. PubMed ID: 2588266
[TBL] [Abstract][Full Text] [Related]
20. Nrf2 is essential for the chemopreventive efficacy of oltipraz against urinary bladder carcinogenesis.
Iida K; Itoh K; Kumagai Y; Oyasu R; Hattori K; Kawai K; Shimazui T; Akaza H; Yamamoto M
Cancer Res; 2004 Sep; 64(18):6424-31. PubMed ID: 15374950
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
